What are the newly approved drugs for SLE and their mechanisms of action?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18847902
Cited by: 0

Abstract

Recently approved drugs for SLE include Belimumab, Anifrolumab, Voclosporin, and Obinutuzumab. They operate by inhibiting B cell activity or specific immune pathways, providing additional therapeutic options for patients.

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Systemic Sclerosis and Related Diseases Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
3 March 2026
Language
EN